162 related articles for article (PubMed ID: 15463856)
1. Assessment of vitamin K deficiency in CF--how much sophistication is useful?
Mosler K; von Kries R; Vermeer C; Saupe J; Schmitz T; Schuster A
J Cyst Fibros; 2003 Jun; 2(2):91-6. PubMed ID: 15463856
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination.
Wilson DC; Rashid M; Durie PR; Tsang A; Kalnins D; Andrew M; Corey M; Shin J; Tullis E; Pencharz PB
J Pediatr; 2001 Jun; 138(6):851-5. PubMed ID: 11391328
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K and the management of patients with cystic fibrosis.
Durie PR
CMAJ; 1994 Oct; 151(7):933-6. PubMed ID: 7922929
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K supplementation for cystic fibrosis.
Jagannath VA; Thaker V; Chang AB; Price AI
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD008482. PubMed ID: 32497260
[TBL] [Abstract][Full Text] [Related]
5. Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis.
Dougherty KA; Schall JI; Stallings VA
Am J Clin Nutr; 2010 Sep; 92(3):660-7. PubMed ID: 20554788
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K supplementation in cystic fibrosis.
van Hoorn JH; Hendriks JJ; Vermeer C; Forget PP
Arch Dis Child; 2003 Nov; 88(11):974-5. PubMed ID: 14612359
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K status in cystic fibrosis patients with liver cirrhosis.
Krzyżanowska P; Drzymała-Czyż S; Pogorzelski A; Duś-Żuchowska M; Skorupa W; Bober L; Sapiejka E; Oralewska B; Rohovyk N; Moczko J; Nowak J; Wenska-Chyży E; Rachel M; Lisowska A; Walkowiak J
Dig Liver Dis; 2017 Jun; 49(6):672-675. PubMed ID: 28185838
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
Strople J; Lovell G; Heubi J
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
[TBL] [Abstract][Full Text] [Related]
9. [Vitamin K deficiency in patients with CF despite supplementation].
Krzyzanowska P; Lisowska A; Skorupa W; Pogorzelski A; Kamińska B; Cichy W; Popiel A; Walkowiak J
Med Wieku Rozwoj; 2010; 14(1):68-72. PubMed ID: 20608431
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E polymorphism and vitamin K status in cystic fibrosis patients not supplemented with vitamin K.
Krzyżanowska-Jankowska P; Walkowiak D; Drzymała-Czyż S; Rohovyk N; Bober L; Walkowiak J
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7077-7082. PubMed ID: 32633402
[TBL] [Abstract][Full Text] [Related]
11. Vitamins K and D status in stages 3-5 chronic kidney disease.
Holden RM; Morton AR; Garland JS; Pavlov A; Day AG; Booth SL
Clin J Am Soc Nephrol; 2010 Apr; 5(4):590-7. PubMed ID: 20167683
[TBL] [Abstract][Full Text] [Related]
12. Exogenous and endogenous determinants of vitamin K status in cystic fibrosis.
Krzyżanowska P; Pogorzelski A; Skorupa W; Moczko J; Grebowiec P; Walkowiak J
Sci Rep; 2015 Jul; 5():12000. PubMed ID: 26160248
[TBL] [Abstract][Full Text] [Related]
13. PIVKA-II plasma levels as markers of subclinical vitamin K deficiency in term infants.
Dituri F; Buonocore G; Pietravalle A; Naddeo F; Cortesi M; Pasqualetti P; Tataranno ML; Agostino R
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1660-3. PubMed ID: 22280352
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of vitamin K deficiency in cystic fibrosis.
Rashid M; Durie P; Andrew M; Kalnins D; Shin J; Corey M; Tullis E; Pencharz PB
Am J Clin Nutr; 1999 Sep; 70(3):378-82. PubMed ID: 10479200
[TBL] [Abstract][Full Text] [Related]
15. Increased PIVKA-II concentrations in patients with cystic fibrosis.
de Montalembert M; Lenoir G; Saint-Raymond A; Rey J; Lefrère JJ
J Clin Pathol; 1992 Feb; 45(2):180-1. PubMed ID: 1541707
[TBL] [Abstract][Full Text] [Related]
16. Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis.
Rana M; Wong-See D; Katz T; Gaskin K; Whitehead B; Jaffe A; Coakley J; Lochhead A
J Clin Pathol; 2014 Jul; 67(7):605-8. PubMed ID: 24711511
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vitamin K deficiency and associated factors in non-supplemented cystic fibrosis patients.
Krzyżanowska P; Drzymala-Czyż S; Rohovyk N; Bober L; Moczkco J; Rachel M; Walkowiak J
Arch Argent Pediatr; 2018 Feb; 116(1):e19-e25. PubMed ID: 29333815
[TBL] [Abstract][Full Text] [Related]
19. Coagulopathy in Zellweger spectrum disorders: a role for vitamin K.
Zeynelabidin S; Klouwer FCC; Meijers JCM; Suijker MH; Engelen M; Poll-The BT; van Ommen CH
J Inherit Metab Dis; 2018 Mar; 41(2):249-255. PubMed ID: 29139025
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease.
Mager DR; McGee PL; Furuya KN; Roberts EA
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):71-6. PubMed ID: 16385257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
